A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Avelumab|DRUG: Aspirin|DRUG: Lansoprazole (Proton Pump Inhibitor)
Sponsor: The Christie NHS Foundation Trust
Collaborators: University of Manchester